Asia Beat: How to feed your dragon
This article was originally published in Scrip
The Lunar New Year doesn't fall until 23 January, but in China there have already been some positive portents for the upcoming year of the dragon, which - blockbuster patent expiries notwithstanding - is seen as an auspicious period.
You may also be interested in...
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.